Santarus has a diverse product development pipeline.
- 17 MAY 13 Santarus Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting
- 15 MAY 13 Santarus Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering
- 10 MAY 13 Santarus Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder
- More News